← SynDRA
RHC80267
SynDRA canonical compound SYN1952817 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | DAGLA | DAGLB | LIPC | LIPE | LIPG |
| Mechanism of action | triacylglycerol lipase inhibitor |
All known targets
- DAGLA
- DAGLB
- LIPC
- LIPE
- LIPG
Mechanisms of action (all sources)
- triacylglycerol lipase inhibitor
- DAGLB INHIBITOR
- DAGLA INHIBITOR
Cross-references
Synonyms
Look up RHC80267 in the interactive SynDRA portal →